Professor Ido Didi Fabian is a leading specialist in ocular oncology, focusing on the diagnosis and management of intraocular tumors and tumors of the ocular surface. His clinical work includes both rare and complex cases, in adults and children.

Professor Fabian combines clinical practice, research activity, and international collaboration, allowing him to apply advanced and modern approaches to eye tumor management.

Clinical Specialization

Professor Ido Didi Fabian specializes in the diagnosis and management of:

Eye Tumors

Uveal Melanoma
Choroidal Nevus
Retinoblastoma
Ocular Lymphoma
Conjunctival Melanoma
Conjunctival Carcinoma

Procedures and Treatment Approaches

Professor Fabian performs and advises on:

Surgery for eye tumors
Ocular surface tumor excision
Plaque brachytherapy
Enucleation surgery
Laser treatments
Cryotherapy
Intraocular injections

Professional Experience

Professor Ido Didi Fabian:

Senior Ocular Oncology Specialist at Sheba Medical Center
Director of Sheba Global Ophthalmology
Chair of Ocular Oncology in Israel
Founder of international retinoblastoma research initiatives

In 2026, Professor Fabian was elected Vice President of the International Society of Ocular Oncology (ISOO) and named President-Elect (2028–2029).

International Activity

Professor Fabian is actively involved in international medical initiatives and consults on complex cases worldwide.

He collaborates with medical centers in:

Africa
Asia
Oceania
Europe
United States

Within these collaborations, Professor Fabian:

Consults complex retinoblastoma cases
Trains physicians
Participates in surgical programs
Develops international treatment protocols

Research Activity

Professor Fabian is:

Faculty member at Tel Aviv University
Professor at London School of Hygiene & Tropical Medicine
Head of the international Retinoblastoma Network (Rb-NET)

He has authored over 100 peer-reviewed publications in international medical journals(PubMed).

Education and Training

Medical Education

MD, Technion – Israel Institute of Technology (with honors)
Ophthalmology residency — Sheba Medical Center
Internship — Sheba Medical Center

Subspecialty Training

Moorfields Eye Hospital, London
Jules Gonin Eye Hospital, Lausanne

Clinical Experience

2023–Present — Director, Sheba Global Ophthalmology
2020–Present — Founder, Ocular Oncology Service, Soroka Medical Center
2017–Present — Senior Ocular Oncology Specialist, Sheba Medical Center

Academic Activity

Chair of Ocular Oncology in Israel
Professor, London School of Hygiene & Tropical Medicine
Faculty Member, Tel Aviv University School of Medicine

Professional Memberships

Professor Fabian is a member of:

International Society of Ocular Oncology (ISOO)
European Ocular Oncology Group
Israeli Ophthalmology Association
International Society of Pediatric Oncology
European Association for Vision Research

Languages

Hebrew
English

Private Consultation

For a private consultation with Professor Ido Didi Fabian:

📞 Phone: +972-73-374-6844
📧 Email: [email protected]
💬 WhatsApp: +972-52-337-3108

Frequently Asked Questions

1. When should I seek care for ocular melanoma in Israel?

Patients usually reach out at different stages. Some contact me right after diagnosis. Others come when a treatment plan has already been suggested and they want another opinion.

Ocular melanoma is relatively rare, and experience matters. My first step is usually reviewing imaging, biopsy results, and prior evaluations.

Sometimes we confirm the original plan. Other times we discuss alternative approaches. Each case is different.

2. When should I consult an ocular oncology specialist in Israel?

I usually tell patients — if something was found in the eye and you’re not completely comfortable with the explanation, it’s reasonable to speak with someone who deals with eye tumors regularly.

Quite often people come after hearing different opinions. Sometimes they were told to just watch it. Sometimes they were advised to treat right away. That can be confusing.

In those situations, I try to slow things down a bit. First, I look at the scans myself. Then we talk about what this actually means and whether anything needs to be done now — or whether it’s safe to wait.

In many cases, the conversation itself already helps patients feel more comfortable with the plan.

3. How does an ocular oncology consultation work?

Most of the time, I start by reviewing the imaging and previous reports. It helps me understand the story before we even talk.

During the consultation, I usually share my screen and go through the images together. I explain what I’m looking at, what seems typical, and what might need closer attention.

Sometimes the next step is straightforward. Other times, I might suggest repeating imaging after a few months or discussing the case with colleagues.

There’s usually no need to rush. My goal is simply to understand the situation clearly and help the patient make a calm, informed decision.

4. How is treatment chosen for an eye tumor?

There’s no single answer. It depends on tumor type, size, and location.

Sometimes observation is appropriate. Sometimes local treatments like brachytherapy or laser therapy are recommended. In more complex situations, we consider combined approaches.

I usually explain the reasoning behind each option so patients can make decisions comfortably.

5. Is it possible to preserve the eye?

In many cases — yes. This is often one of our main goals.

Modern treatment options allow us to control tumors while preserving the eye and sometimes vision. The approach depends on the specific situation.

6. Can I start with an online consultation?

Yes, and actually many patients prefer to start this way — especially if they live far away or just want an initial opinion.

I usually ask patients to send imaging and reports in advance. I go through everything carefully before the meeting. Then during the consultation we talk through the situation and possible next steps.

Sometimes one consultation is enough to clarify things. Sometimes we decide to continue the evaluation. It really depends on the case.

There are no reviews yet. Be the first one to write one.